Seed round raised from existing investors (True Ventures, BKR Capital, Centre for Aging and Brain Health Innovation, Health2047 and others) - $4.5M to date. Securing of MassAITC pilot funding helped in due diligence with investors for their seed round, and thus was critical to closing their funding including with Health2047, venture arm of the American Medical Association and with other early stage investors. Source: businesswire
"We are excited to partner with Moneta to make personalized, evidence-based cognitive rehabilitation the standard of care for our patients and families. Montana is vast and has the sixth oldest population in the nation. Moneta’s proven program is an accessible approach to proactive brain health for our aging demographic." Dr. Greg Tierney, President of System Clinical Operations at Benefis Health System. LAS VEGAS--(BUSINESS WIRE)--Moneta Health, a brain health company pioneering cognitive rehabilitation therapy through AI-powered delivery, today announced a $4.5 million funding round and a new partnership with Benefis Health System to expand access to cognitive care in neurology deserts. The company has signed a multi-year partnership with Benefis Health System in Montana and secured investment from venture capital firms including True Ventures and Health2047, the American Medical Association’s venture studio, to support its mission…
Title: Improving Access to Dementia Care through AI-Powered Cognitive Rehabilitation Therapy Authors: Jennifer Flexman Abstract: Forthcoming
Jennifer Flexman presented "Improving Access to Dementia Care though AI-Powered Cognitive Rehabilitation Therapy" at the Technology And Dementia Preconference during Session 5: Data Blitz.
Title: AI-powered Digital Therapy Assistant to Monitor and Treat Cognitive Impairment in Older Adults Over the Phone Authors: Jen Flexman, Jessoe Ng, Corinna Serviente, Rayhnuma Ahmed, Paul Campbell, Rebecca Vaughan Darwish, Susan Kane, Erin Smith, Michael Busa
What they said: Moneta Health is like physical therapy for the brain, delivered through a traditional phone call for maximum accessibility. It’s an elegantly simple sounding idea, but the Moneta team has a few important things going for them that make us particularly excited to support them. In Campbell and Flexman, they have a powerful combination of experience, combining digital health operational ability with engineering and deep knowledge of neurodegeneration. They’re also very smart in their go-to-market strategy. By showing strong early results in terms of improving cognitive function and patient quality of life (with more trials to come), they’re securing big name referring partners. They’re also tapping into known reimbursement codes, so that they can generate revenue to feed product development. And, as we have found to be so important in this market of…